alexa Serum Micro RNA 143 As A Potential Biomarker For The Diagnosis Of Hepatitis C Virus Related Hepatocellular Carcinoma
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

16th Global Annual Oncologists Meeting
April 24-25, 2017 Dubai, UAE

Essam Alaaeldin Elzoheiry, Ahmed Mohamed El-Gohary, Ahmed Elsayed Zeid, Mohamed Eid Ibrahim and Fatma Ibrahim Dewedar
Alexandria University, Egypt
Posters & Accepted Abstracts: J Cancer Sci Ther
DOI: 10.4172/1948-5956-C1-097
Abstract
Background: Hepatocellular carcinoma is the 5th most frequently diagnosed cancer worldwide, and is the 2nd leading cause of cancer-related death in the world. HCC has a poor prognosis and most patients die within 1 year of diagnosis. Early recognition of the onset of HCC would help to select more effective therapies for patients leading to a better prognosis and life span. Though the measurement of AFP serves as an important tool in screening of HCC, some reports have indicated that it has limited utility of differentiating HCC from benign hepatic disorders. So, the development of effective marker for the diagnosis of HCC could have an impact on HCC-related cancer mortality. MicroRNAs are reported as a group of small non-coding RNAs that can function as endogenous RNA interference to regulate expression of the targeted genes. Aim: The aim of this work is to study serum miR-143 expression level in patients with HCV-related HCC. Methods: The present study was conducted on 60 subjects who attended the main Alexandria University Hospital during the period from April 2016 to the end of July 2016 and the subjects were divided into Group (A): 30 patients with HCVrelated cirrhosis with HCC, Group (B): 15 patients with HCV-related cirrhosis without HCC and Group (C): Healthy subjects as control. Total serum RNA was extracted with small RNA enrichment followed by reverse transcription real time PCR. Expression of miR-143 in the serum of all subjects was obtained using the comparative cycle threshold (CT) method (2– ΔΔCT) after normalization for the expression of Syn-cel-miR-39 mi script miRNA mimic as control. MiR-143 expression levels were then compared in different groups. Results: The mean serum miR-143 levels were significantly higher in cirrhotic patients without and with HCC than in healthy subjects (1.69±0.64 and 13.0±6.23 vs. 0.56±0.29 respectively) and in patients with HCC than in patients without HCC (Kruskal Wallis test, x2=49.408, P<0.001). The mean serum miR-143 levels were significantly higher in cirrhotic patients with HCC BCLC stage D than in HCC patients with BCLC stage B than in HCC patients with BCLC stage A (19.91±2.40, 13.41±1.80 and 5.68±1.86 respectively). ROC curve was plotted to detect the potential application of miR-143 in the diagnosis of liver cirrhosis and HCC post HCV. Our results showed that miR-143 could serve as valuable biomarkers for HCV related cirrhosis and HCC. Conclusion: Serum level of miR-143 is significantly higher in cirrhotic patients with early HCC than in cirrhotic patients without HCC which may suggest its role in hepatocarcinogenesis. Serum levels of miR-143 showed significant increase in HCV-related cirrhosis and HCC in comparison with healthy subjects with its high sensitivity and specificity in detecting HCC value as a potential biomarker for early diagnosis of HCV-related HCC.
Biography

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords